Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer

Tamoxifen (TAM) has been prescribed for decades and aromatase inhibitors (AIs) have been used since the early 2000s in preventing subsequent breast cancer. However, outside of clinical trials, the effectiveness of AIs is not established. We examined the long-term risk of subsequent breast cancer amo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Haque, Reina, Ahmed, Syed A, Fisher, Alice, Avila, Chantal C, Shi, Jiaxiao, Guo, Amy, Craig Cheetham, T, Schottinger, Joanne E
Format: Artigo
Idioma:Inglês
Publicat: WILEY-VCH Verlag 2012
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3544463/
https://ncbi.nlm.nih.gov/pubmed/23342281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.37
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars